Bicycle Therapeutics plc (BCYC) Misses Q3 EPS by 7c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/31/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. MA
9. FND
10. DASH

Go back to Bicycle Therapeutics plc (BCYC) Misses Q3 EPS by 7c

Bicycle Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update

November 3, 2022 7:00 AM EDT

- Continued clinical progress across pipeline including BT5528 end of Phase I dose escalation update; completion of enrollment in BT5528 initial dose expansion cohorts expected in Q4

- BT8009 clinical update remains on-track for Q4

- Received $10 million option fee payment from Genentech this quarter triggered by exclusive strategic collaboration expansion option exercise in Q2

- Cash and cash equivalents of $361.5 million as of September 30, 2022; expected financial runway into 2025

CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)-- Bicycle Therapeutics plc... More